ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $114,000 | -57.8% | 22,771 | +1.5% | 0.00% | – |
| Q3 2021 | $270,000 | +24.4% | 22,425 | +119.0% | 0.00% | – |
| Q2 2021 | $217,000 | -18.1% | 10,241 | +8.3% | 0.00% | – |
| Q1 2021 | $265,000 | -71.7% | 9,457 | -73.8% | 0.00% | -100.0% |
| Q4 2020 | $938,000 | +68.1% | 36,091 | +140.2% | 0.00% | 0.0% |
| Q3 2020 | $558,000 | +151.4% | 15,024 | +247.4% | 0.00% | – |
| Q2 2020 | $222,000 | -51.8% | 4,325 | -53.0% | 0.00% | -100.0% |
| Q3 2017 | $461,000 | +2.9% | 9,205 | -4.8% | 0.00% | 0.0% |
| Q2 2017 | $448,000 | -37.2% | 9,673 | -52.1% | 0.00% | -50.0% |
| Q1 2017 | $713,000 | – | 20,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |